COVID-19 Myopericarditis in a Young Healthy Male

  • Matilde Bandeira erviço de Reumatologia, Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal; Unidade de Investigação em Reumatologia, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Centro Académico de Medicina de Lisboa, Lisbon, Portugal
  • Juliana Serrazina Serviço de Gastrenterologia e Hepatologia, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal
  • Carolina António Santos Serviço de Medicina II, Clínica Universitária Medicina II, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal
  • Nuno Jacinto Serviço de Medicina II, Clínica Universitária Medicina II, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal; Critical Care Department, Hospital Professor Doutor Fernando da Fonseca, Amadora, Portugal
  • António Pais de Lacerda Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal; Critical Care Department, Hospital Professor Doutor Fernando da Fonseca, Amadora, Portugal

Keywords

Myopericarditis, COVID-19, SARS-CoV-2

Abstract

SARS-CoV-2 infection can present in different clinical forms, most commonly as bilateral pneumonia, but also with pericardial/myocardial involvement. Cardiac involvement in COVID-19 is associated with worse outcomes.
The authors report a case of myopericarditis as the primary manifestation of SARS-CoV-2 infection in a 20-year-old male patient with no known cardiovascular (CV) disorders or risk factors. 
The patient presented with pleuritic chest pain and high fever, with no respiratory symptoms. Electrocardiogram (ECG) and echocardiogram changes were consistent with pericarditis; concomitant elevation of cardiac enzymes revealed myocardial involvement. The patient had a slow but favourable evolution with no apparent impact on cardiac function. Other causes of myopericarditis were excluded and SARS-CoV-2 admitted as the most likely aetiological agent. 
This case highlights possible cardiac involvement in SARS-CoV-2 infection with little or no pulmonary disease in a young healthy patient. Such systemic and potentially troublesome manifestations of COVID-19 are increasingly being described.

VIEW THE ENTIRE ARTICLE

References

  • Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000;87(5):E1–9. doi:10.1161/01.res.87.5.e1
  • Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med 2020;14(2):185–192. doi:10.1007/s11684-020-0754-0
  • Imazio M, Trinchero R. Myopericarditis: etiology, management, and prognosis. Int J Cardiol 2008;127(1):17–26. doi:10.1016/j.ijcard.2007.10.053
  • Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol 2020 Jul 1;5(7):802–810. doi:10.1001/jamacardio.2020.0950
  • Xiong T-Y, Redwood S, Prendergast B, Chen M. Coronaviruses and the cardiovascular system: acute and long-term implications. Eur Heart J 2020;41(19):1798–1800. doi:10.1093/eurheartj/ehaa231
  • Giustino G, Pinney SP, Lala A, Reddy VY, Johnston-Cox HA, Mechanick JI, et al. Coronavirus and cardiovascular disease, myocardial injury, and arrhythmia: JACC Focus Seminar. J Am Coll Cardiol 2020;76(17):2011–2023. doi:10.1016/j.jacc.2020.08.059
  • Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020;8(4):420–422. doi:10.1016/S2213-2600(20)30076-X
  • Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2015;36(42):2921–2964. doi:10.1093/eurheartj/ehv318
  • Mansi I. Electrocardiographic diagnosis of pericarditis. JAMA 2003;289(22):2942; author reply 2942–2943. doi:10.1001/jama.289.22.2942-a
  • Kumar R, Kumar J, Daly C, Edroos SA. Acute pericarditis as a primary presentation of COVID-19. BMJ Case Rep 2020;13(8):e237617. doi:10.1136/bcr-2020-237617
  • Diaz-Arocutipa C, Saucedo-Chinchay J, Imazio M. Pericarditis in patients with COVID-19: a systematic review. J Cardiovasc Med (Hagerstown) 2021;22(9):693–700.
  • Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020 Jul 1;5(7):811–818. doi:10.1001/jamacardio.2020.1017
  • Imazio M, Demichelis B, Cecchi E, Belli R, Ghisio A, Bobbio M, et al. Cardiac troponin I in acute pericarditis. J Am Coll Cardiol 2003;42(12):2144–2148. doi:10.1016/j.jacc.2003.02.001
  • Bandeira M, Gil Â, Santos AC, Romão VC, Mascarenhas MR, Filipe P, et al. Angiotensin-converting enzyme activity may predict disease severity in psoriasis. Rheumato 2022;2(1):15–23. doi:10.3390/rheumato2010003
  • Abdollahimajd F, Niknezhad N, Haghighatkhah HR, Namazi N, Niknejad N, Talebi A. Angiotensin-converting enzyme and subclinical atherosclerosis in psoriasis: is there any association? A case-control study. J Am Acad Dermatol 2020;82(4):980–981.e1. doi:10.1016/j.jaad.2018.08.003
  • Shahidi-Dadras M, Tabary M, Robati RM, Araghi F, Dadkhahfar S. Psoriasis and risk of the COVID-19: is there a role for angiotensin converting enzyme (ACE)? J Dermatolog Treat 2022 Mar;33(2):1175–1176. doi:10.1080/09546634.2020.1782819
  • Published: 2022-05-23

    Issue: 2022: Vol 9 No 5 (view)

    Section: Articles

    How to cite:
    1.
    Bandeira M, Serrazina J, Santos CA, Jacinto N, Pais de Lacerda A. COVID-19 Myopericarditis in a Young Healthy Male. EJCRIM 2022;9 doi:10.12890/2022_003361.